Search Results - "BEHBAKHT, K"

On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics by Dimberg, L Y, Anderson, C K, Camidge, R, Behbakht, K, Thorburn, A, Ford, H L

“…Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and agonistic antibodies against TRAIL death receptors (DR) kill tumor cells while causing…”
Get full text

Gab2 regulates the migratory behaviors and E-cadherin expression via activation of the PI3K pathway in ovarian cancer cells by Wang, Y, Sheng, Q, Spillman, M A, Behbakht, K, Gu, H

“…Ovarian cancer, the most deadly gynecologic malignancy, is often diagnosed late and at the advanced stage when the cancer cells have already migrated and…”
Get full text

Brachytherapy Should Not be Omitted When Treating Locally Advanced Neuroendocrine Cervical Cancer with Definitive Chemoradiation Therapy by Robin, T.P, Amini, A, Behbakht, K, Fisher, C.M

Get full text

PARPi after PARPi in epithelial ovarian cancer by Essel, K.G., Behbakht, K., Lai, T., Hand, L., Evans, E., Dvorak, J., Ding, K., Konecny, G., Moore, K.N.

“…•The indication for treatment of ovarian cancer with a PARP inhibitor is expanding.•Prior exposure to a PARP inhibitor does not necessarily confer resistance…”
Get full text

Minority race is a significant risk factor for treatment by non-gynecologic oncologists in women with pelvic malignancies by Ramzan, A.A, Behbakht, K, Corr, B.R, Sheeder, J, Guntupalli, S.R

Get full text

Effect of estrogen therapy on ovarian tumor cells treated with cisplatin by Cheng, G, Galimanis, C, Lefkowits, C, Baumgartner Wilson, H, Behbakht, K

Get full text

Identification of activated estrogen receptor signaling targets in ovarian cancer by Cheng, G, Behbakht, K, Spillman, M

Get full text

Histopathology discrepancy of preoperative endometrial sampling and final specimen: How does this influence selective lymph node dissection? by Corr, B.R, Carrubba, A.R, Sheeder, J, Cheng, G, Behbakht, K, Guntupalli, S.R

Get full text

Bevacizumab-induced hypertension in gynecological cancer: Does it resolve after completion of therapy? by Corr, B.R, Breed, C, Sheeder, J, Weisdack, S, Guntupalli, S.R, Lefkowits, C, Behbakht, K

Get full text

A multiinstitutional, prospective randomized open-blinded end-point trial for safety of oral apixaban versus subcutaneous enoxaparin for thromboprophylaxis in women with suspected gynecologic malignancy by Guntupalli, S.R, Brennecke, A, Sheeder, J, Babayan, L.M, Cheng, G, Behbakht, K, Corr, B.R, Lefkowits, C, Matsuo, K, Flink, D.M

Get full text

A prospective, randomized, open-blinded endpoint (PROBE) trial for safety of oral apixaban vs subcutaneous enoxaparin for thromboprophylaxis in women with a suspected gynecologic malignancy by Guntupalli, S.R, Brennecke, A, Sheeder, J, Cheng, G, Behbakht, K, Babayan, L.M, Corr, B.R, Lefkowits, C, Matsuo, K, Flink, D.M

Get full text

Awareness of symptoms and risk factors of ovarian cancer in a population of women and health care providers by Medlin, E, Goldstein, C, Susman, E, Lockwood, S, Behbakht, K

Get full text

Identification of a gene expression signature to distinguish uterine leiomyosarcomas from leiomyomas by Adams, C.L, Gibson, L, Behbakht, K, Spillman, M.A, Bradford, A.P

Get full text

Postoperative pulmonary complications are increased among obese patients undergoing robotic surgery for suspected gynecologic malignancy by Sheeder, J, Arruda, J, Guntupalli, S.R, Davidson, S.A, Behbakht, K

Get full text

OB/GYN residency inadequately prepares residents for fellowship training in gynecologic oncology: Results of national, multi-institutional survey by Doo, D, Guy, M.S, Powell, M.A, Novetsky, A.P, Sheeder, J.S, Behbakht, K

Get full text

Effect of preoperative chemotherapy on postoperative morbidity and mortality in patients undergoing surgery for ovarian cancer by Doo, D, Guy, M, Behbakht, K, Davidson, S, Sheeder, J, Guntupalli, S

Get full text

Prolonged steep Trendelenburg positioning increases the risk of postoperative morbidity in patients undergoing robotic surgery for presumed gynecologic malignancy by Sheeder, J, Arruda, J, Guntupalli, S.R, Davidson, S.A, Behbakht, K

Get full text

Cytokeratin 5 positive cells represent a therapy resistant subpopulation in epithelial ovarian cancer by Finlay-Schultz, J, Rosen, R, Qamar, L, Post, M, Behbakht, K, Spillman, M, Sartorius, C

Get full text

Comparative surgical outcomes in endometrial cancer patients staged with robotics or laparotomy 65 years and older by Corr, B, Spillman, M.A, Behbakht, K, Davidson, S.A, Sheeder, J, Guntupalli, S.R

Get full text

A randomized phase III trial of gemcitabine + docetaxel + bevacizumab or placebo as first-line treatment for metastatic uterine leiomyosarcoma (uLMS): A Gynecologic Oncology Group study by Miller, A, O'Malley, D.M, Mannel, R.S, Behbakht, K, Bakkum-Gamez, J.N, Michael, H

Get full text